|
시장보고서
상품코드
1745935
세계의 분자 이미징 시장 : 시장 규모, 점유율, 동향, 업계 분석 - 모달리티별, 용도별, 최종 용도별, 지역별, 예측(2025-2034년)Molecular Imaging Market Size, Share, Trends, Industry Analysis Report: By Modality, By Application, By End Use (Hospitals, Diagnostics Imaging Centers, and Research Institutes), and Region- Forecast, 2025-2034 |
||||||
Polaris Market Research의 최근 조사에 따르면 분자 이미징 시장 규모는 2034년까지 139억 7,000만 달러에 이를 것으로 예측됩니다. 이 보고서는 현재의 시장 역학을 자세히 파악하고 미래의 시장 성장에 대한 분석을 제공합니다.
분자 이미징은 생체 내 분자 및 세포 수준의 생물학적 과정을 시각화하고 측정하는 의료 기술이며 조기 및 정확한 질병 진단을 가능하게 합니다.
정부와 대학, 비공개 회사는 의료기술의 연구개발(R&D)에 대한 투자를 늘리고 있습니다. 이러한 투자는 과학자들이 새로운 이미징제를 발견하고 기존의 이미징 장치를 개량하는 데 도움이 되고 있습니다. 또한 더 많은 자금이 투입됨으로써 연구가 실제 의료 도구가 되기까지의 과정도 속도를 내고 있습니다. 그 결과, 보다 고도로 효과적인 분자 이미징 제품이 시장에 유통되고 있습니다. 이러한 기술 혁신에 대한 지속적인 지원은 질병 진단과 치료의 새로운 방법을 개발하기 위해 필수적이며 분자 이미징 솔루션에 대한 수요는 전 세계적으로 높아지고 있습니다.
과거에는 새로운 이미징 약물과 기술이 임상용으로 승인되기까지 수년이 걸렸습니다. 그러나 FDA나 EMA와 같은 규제 기관은 현재 안전하고 효과적인 제품을 보다 빨리 시장에 투입할 수 있도록 그 프로세스를 합리화하고 있습니다. 이러한 경로 개선은 기업이 새로운 분자 이미징 도구를 개발하고 출시하는 것을 뒷받침합니다. 승인이 빨라진다는 것은 병원이나 진료소에서의 채용이 빨라진다는 것이며, 환자가 최신 기술의 혜택을 더 빨리 받을 수 있게 됩니다. 이러한 규제 당국의 지원으로 분자 이미징 시장의 혁신과 성장에 보다 유리한 환경이 조성되고 있습니다.
분자 이미징 시장 : 분석 개요
2024년에는 첨단 장비와 복잡한 작업을 수행하는 숙련된 전문가를 사용할 수 있기 때문에 병원 부문이 분자 이미징 시장을 독점했습니다.
심혈관 부문은 세계 심혈관 질환의 유병률이 증가함에 따라 예측 기간 동안 큰 성장이 예상됩니다.
2024년 시점에서는 의료 인프라가 정비되어 의료 기술에 대한 투자가 활발한 북미가 시장을 독점하고 있습니다.
아시아태평양은 중국, 일본, 한국 등 국가의 의료 인식 증가, 투자 증가, 의료 인프라 확대로 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예측됩니다.
세계의 주요 기업으로는 Bruker, Canon Medical Systems Corporation, Cubresa Inc., GE HealthCare, Koninklijke Philips N.V., Mediso Ltd., Positron, Shimadzu Corporation, Siemens Healthineers AG, and United Imaging Healthcare Co. Ltd 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 세계의 분자 이미징 시장 인사이트
- 시장 현황
- 분자 이미징 시장 역학
- 성장 촉진요인 및 기회
- 만성질환 유병률 상승
- 고령화 인구 증가
- 성장 억제요인 및 과제
- 높은 초기 비용
- 여론 및 프라이버시에 관한 판례
- 성장 촉진요인 및 기회
- PESTEL 분석
- 분자 이미징 시장 동향
- 밸류체인 분석
제5장 세계의 분자 이미징 시장 : 모달리티별
- 주요 분석 결과
- 서문
- 분자 초음파 이미징
- 양전자 방출 단층 촬영(PET)
- 단일 광자 방출 컴퓨터 단층 촬영(SPECT)
- 핵자기 공명(NMR) 분광계
- 기타
제6장 세계의 분자 이미징 시장 : 용도별
- 주요 분석 결과
- 서문
- 심혈관계
- 신경학
- 종양
- 호흡기
- 위장
제7장 세계의 분자 이미징 시장 : 최종 용도별
- 주요 분석 결과
- 서문
- 병원
- 진단 이미지 센터
- 연구기관
제8장 세계의 분자 이미징 시장 : 지역별
- 주요 분석 결과
- 서문
- 분자 이미징 시장의 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 모달리티별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 모달리티별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 모달리티별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 모달리티별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 모달리티별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴, 협업, 합의 및 공개
제10장 기업 프로파일
- Bruker
- Canon Medical Systems Corporation
- Cubresa Inc.
- GE HealthCare
- Koninklijke Philips NV
- Mediso Ltd.
- Positron
- Shimadzu Corporation
- Siemens Healthineers AG
- United Imaging Healthcare Co., Ltd.
The molecular imaging market size is expected to reach USD 13.97 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Imaging Market Size, Share, & Industry Analysis Report: By Modality, By Application, By End Use (Hospitals, Diagnostics Imaging Centers, and Research Institutes), and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Molecular imaging is a medical technique that visualizes and measures biological processes at the molecular and cellular levels within living organisms, enabling early and precise disease diagnosis.
Governments, universities, and private companies are investing more in research and development (R&D) for healthcare technologies. These investments are helping scientists discover new imaging agents and improve existing imaging machines. More funding also speeds up the process of turning research into real-world medical tools. As a result, more advanced and effective molecular imaging products are entering the market. This ongoing support for innovation is essential for developing new ways to diagnose and treat diseases, which increases the demand for molecular imaging solutions across the globe.
In the past, getting new imaging agents and technologies approved for clinical use could take many years. However, regulatory agencies such as the FDA and EMA are now streamlining their processes to help bring safe and effective products to market faster. These improved pathways encourage companies to develop and launch new molecular imaging tools. Faster approvals mean quicker adoption by hospitals and clinics, which helps patients benefit from the latest technologies sooner. This regulatory support is creating a more favorable environment for innovation and growth in the molecular imaging market.
Molecular Imaging Market Report Highlights
In 2024, the hospital segment dominated the molecular imaging market due to the availability of high-end equipment and skilled professionals to perform complex tasks.
The cardiovascular segment is expected to witness significant growth during the forecast period due to the rising prevalence of cardiovascular disease worldwide.
In 2024, North America dominated the market due to its well-established healthcare infrastructure and strong investments in medical technology.
Asia Pacific is expected to record the highest CAGR in the forecast period, driven by increasing healthcare awareness, rising investments, and expanding medical infrastructure in countries such as China, Japan, and South Korea.
A few global key market players are Bruker; Canon Medical Systems Corporation; Cubresa Inc.; GE HealthCare; Koninklijke Philips N.V.; Mediso Ltd.; Positron; Shimadzu Corporation; Siemens Healthineers AG; and United Imaging Healthcare Co., Ltd.
Polaris Market Research has segmented the molecular imaging market report on the basis of modality, application, end use, and region:
By Modality (Revenue - USD Billion, 2020-2034)
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Others
By Application (Revenue - USD Billion, 2020-2034)
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
By End Use (Revenue - USD Billion, 2020-2034)
Hospitals
Diagnostic Imaging Centers
Research Institutes
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Molecular Imaging Market Insights
- 4.1. Molecular Imaging Market - Market Snapshot
- 4.2. Molecular Imaging Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Chronic Disease
- 4.2.1.2. Growing Geriatric Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Cost
- 4.2.3. Public opinion and privacy legal precedents
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Molecular Imaging Market Trends
- 4.6. Value Chain Analysis
5. Global Molecular Imaging Market, by Modality
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 5.3. Molecular Ultrasound Imaging
- 5.3.1. Global Molecular Imaging Market, by Molecular Ultrasound Imaging, by Region, 2020-2034 (USD Billion)
- 5.4. Positron Emission Tomography (PET)
- 5.4.1. Global Molecular Imaging Market, by Positron Emission Tomography (PET), by Region, 2020-2034 (USD Billion)
- 5.5. Single Photon Emission Computed Tomography (SPECT)
- 5.5.1. Global Molecular Imaging Market, by Single Photon Emission Computed Tomography (SPECT), by Region, 2020-2034 (USD Billion)
- 5.6. Nuclear Magnetic Resonance (NMR) Spectrometer
- 5.6.1. Global Molecular Imaging Market, by Nuclear Magnetic Resonance (NMR) Spectrometer, by Region, 2020-2034 (USD Billion)
- 5.7. Others
- 5.7.1. Global Molecular Imaging Market, by Others, by Region, 2020-2034 (USD Billion)
6. Global Molecular Imaging Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 6.3. Cardiovascular
- 6.3.1. Global Molecular Imaging Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
- 6.4. Neurology
- 6.4.1. Global Molecular Imaging Market, by Neurology, by Region, 2020-2034 (USD Billion)
- 6.5. Oncology
- 6.5.1. Global Molecular Imaging Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 6.6. Respiratory
- 6.6.1. Global Molecular Imaging Market, by Respiratory, by Region, 2020-2034 (USD Billion)
- 6.7. Gastrointestinal
- 6.7.1. Global Molecular Imaging Market, by Gastrointestinal, by Region, 2020-2034 (USD Billion)
7. Global Molecular Imaging Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Molecular Imaging Market, by Hospital, by Region, 2020-2034 (USD Billion)
- 7.4. Diagnostic Imaging Centers
- 7.4.1. Global Molecular Imaging Market, by Diagnostic Imaging Centers, by Region, 2020-2034 (USD Billion)
- 7.5. Research Institutes
- 7.5.1. Global Molecular Imaging Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)
8. Global Molecular Imaging Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Molecular Imaging Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Molecular Imaging Market - North America
- 8.3.1. North America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.3.2. North America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Molecular Imaging Market - US
- 8.3.4.1. US: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.3.4.2. US: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.3.4.3. US: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Molecular Imaging Market - Canada
- 8.3.5.1. Canada: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4. Molecular Imaging Market - Europe
- 8.4.1. Europe: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.2. Europe: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Molecular Imaging Market - UK
- 8.4.4.1. UK: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Molecular Imaging Market - France
- 8.4.5.1. France: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.5.2. France: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.5.3. France: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Molecular Imaging Market - Germany
- 8.4.6.1. Germany: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Molecular Imaging Market - Italy
- 8.4.7.1. Italy: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Molecular Imaging Market - Spain
- 8.4.8.1. Spain: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Molecular Imaging Market - Netherlands
- 8.4.9.1. Netherlands: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Molecular Imaging Market - Russia
- 8.4.10.1. Russia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Molecular Imaging Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5. Molecular Imaging Market - Asia Pacific
- 8.5.1. Asia Pacific: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Molecular Imaging Market - China
- 8.5.4.1. China: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.4.2. China: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.4.3. China: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Molecular Imaging Market - India
- 8.5.5.1. India: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.5.2. India: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.5.3. India: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Molecular Imaging Market - Malaysia
- 8.5.6.1. Malaysia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Molecular Imaging Market - Japan
- 8.5.7.1. Japan: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Molecular Imaging Market - Indonesia
- 8.5.8.1. Indonesia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Molecular Imaging Market - South Korea
- 8.5.9.1. South Korea: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Molecular Imaging Market - Australia
- 8.5.10.1. Australia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Molecular Imaging Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.6. Molecular Imaging Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Molecular Imaging Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Molecular Imaging Market - UAE
- 8.6.5.1. UAE: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Molecular Imaging Market - Israel
- 8.6.6.1. Israel: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Molecular Imaging Market - South Africa
- 8.6.7.1. South Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Molecular Imaging Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.7. Molecular Imaging Market - Latin America
- 8.7.1. Latin America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Molecular Imaging Market - Mexico
- 8.7.4.1. Mexico: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Molecular Imaging Market - Brazil
- 8.7.5.1. Brazil: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Molecular Imaging Market - Argentina
- 8.7.6.1. Argentina: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Molecular Imaging Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Molecular Imaging Market, by Modality, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Molecular Imaging Market, by Application, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Molecular Imaging Market, by End Use, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Bruker
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Canon Medical Systems Corporation
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Cubresa Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. GE HealthCare
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Koninklijke Philips N.V.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Mediso Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Positron
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Shimadzu Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Siemens Healthineers AG
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. United Imaging Healthcare Co., Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
